Description
This assay uses the Luminex® 200™ platform.
Our featured assay wells are available in limited quantities, priced attractively for market testing. If we’re unable to fulfill your request, we’ll promptly inform you of the available quantity. We appreciate your understanding and interest in our offerings!
Consider this assay for a targeted analysis of key circulating cancer biomarkers. The Human Circulating Cancer Biomarker Panel 3 4-Plex Assay (HCCBP3-04-11) measures biomarkers such as Cathepsin D, Ferritin, Fibroblast Activation Protein, and Myeloperoxidase.
Ideal for studies focusing on cancer detection and monitoring, this panel helps elucidate the role of these biomarkers in tumor progression and response to treatment. For example, Ferritin is often used to assess iron metabolism and inflammatory responses in cancer, while Myeloperoxidase can indicate oxidative stress related to cancer development. Cathepsin D, an enzyme involved in protein degradation, is associated with tumor aggressiveness, and Fibroblast Activation Protein is linked to the tumor microenvironment and cancer progression.
This assay is particularly valuable for investigating the molecular mechanisms underlying cancer and evaluating potential therapeutic targets. It provides insights into the dynamics of these biomarkers in various cancer types and can aid in assessing disease prognosis and therapeutic efficacy.
Discover the power of precision with our Human Circulating Cancer Biomarker Panel 3 4-Plex Assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays